Structure Therapeutics Inc ADR [GPCR] stock is trading at $27.09, down -0.88%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GPCR shares have gain 14.11% over the last week, with a monthly amount glided 59.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Structure Therapeutics Inc ADR [NASDAQ: GPCR] stock has seen the most recent analyst activity on May 02, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $60. On January 08, 2025, Stifel initiated with a Buy rating and assigned a price target of $50 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $80 on December 04, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $118 as its price target on September 23, 2024. JP Morgan started tracking with a Overweight rating for this stock on May 21, 2024, and assigned it a price target of $65. In a note dated April 09, 2024, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $65 on this stock.
Structure Therapeutics Inc ADR [GPCR] stock has fluctuated between $13.22 and $62.74 over the past year. Currently, Wall Street analysts expect the stock to reach $92.4 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $27.09 at the most recent close of the market. An investor can expect a potential return of 241.09% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.16 and Total Capital is -0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.51 points at the first support level, and at 25.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.17, and for the 2nd resistance point, it is at 29.26.
Ratios To Look Out For
For context, Structure Therapeutics Inc ADR’s Current Ratio is 24.74. Also, the Quick Ratio is 24.74, while the Cash Ratio stands at 4.71.
